Lineage Cell Therapeutics, Inc. · AMEX:LCTX
Culley Brian M bought 40,500 Lineage Cell Therapeutics, Inc. shares (Form 4)
Traded Nov 16, 2026 · Filed Nov 17, 2026
On Nov 16, 2026, Culley Brian M (Director, President and CEO) bought 40,500 Lineage Cell Therapeutics, Inc. shares at US$0.92 for US$37,098, leaving 296,016 shares. Filed Nov 17, 2026 (Form 4).
- Bought
- 40,500 shares
- Price
- US$0.92
- Value
- US$37,098
- Holding after
- 296,016 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Common Shares | Buy | 40,500 | US$0.92 | 296,016 | Direct |
Source
Download original · View original at SEC
Related
- Lineage Cell Therapeutics, Inc.
- Culley Brian M
- Lineage Cell Therapeutics, Inc. shareholders
- Form 4 · Mulroy Michael H. · Nov 19, 2026
- Form 4 · Broadwood Partners, L.P. · Nov 19, 2026
- Form 4 · Andrews Deborah J · Nov 17, 2026
- Form 4 · Howe Jill Ann · Nov 16, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026